Early recognition of poor prognosis in Guillain-Barré syndrome
- 15 March 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 76 (11), 968-975
- https://doi.org/10.1212/wnl.0b013e3182104407
Abstract
Background: Guillain-Barré syndrome (GBS) has a highly diverse clinical course and outcome, yet patients are treated with a standard therapy. Patients with poor prognosis may benefit from additional treatment, provided they can be identified early, when nerve degeneration is potentially reversible and treatment is most effective. We developed a clinical prognostic model for early prediction of outcome in GBS, applicable for clinical practice and future therapeutic trials. Methods: Data collected prospectively from a derivation cohort of 397 patients with GBS were used to identify risk factors of being unable to walk at 4 weeks, 3 months, and 6 months. Potential predictors of poor outcome (unable to walk unaided) were considered in univariable and multivariable logistic regression models. The clinical model was based on the multivariable logistic regression coefficients of selected predictors and externally validated in an independent cohort of 158 patients with GBS. Results: High age, preceding diarrhea, and low Medical Research Council sumscore at hospital admission and at 1 week were independently associated with being unable to walk at 4 weeks, 3 months, and 6 months (all p 0.05–0.001). The model can be used at hospital admission and at day 7 of admission, the latter having a better predictive ability for the 3 endpoints; the area under the receiver operating characteristic curve (AUC) is 0.84–0.87 and at admission the AUC is 0.73–0.77. The model proved to be valid in the validation cohort. Conclusions: A clinical prediction model applicable early in the course of disease accurately predicts the first 6 months outcome in GBS.Keywords
This publication has 31 references indexed in Scilit:
- Distinguishing acute-onset CIDP from fluctuating Guillain-Barré syndromeNeurology, 2010
- Predicting functional outcome after stroke by modelling baseline clinical and CT variablesAge and Ageing, 2010
- Baseline characteristics and statistical power in randomized controlled trials: Selection, prognostic targeting, or covariate adjustment?*Critical Care Medicine, 2009
- Treatment of Guillain Barre syndrome with mycophenolate mofetil: a pilot studyJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirementsJournal of Clinical Epidemiology, 2004
- Clinical trials in acute myocardial infarction: Should we adjust for baseline characteristics?American Heart Journal, 2000
- The prognosis and main prognostic indicators of Guillain-Barré syndrome A multicentre prospective study of 297 patientsBrain, 1996
- Brain swelling in first hour after coronary artery bypass surgeryThe Lancet, 1993
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991
- CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHYThe Lancet, 1978